Susquehanna International Group, LLP Pax Medica, Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.27 - $0.88 $8,379 - $27,309
31,034 New
31,034 $8,000
Q1 2023

May 16, 2023
BUY
$1.42 - $3.62 $19,422 - $49,514
13,678 New
13,678 $26,000

About PaxMedica, Inc.

PXMD Quotes by TradingView
  • Ticker PXMD
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,779,500
  • Market Cap $1.06M
  • Description
  • PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, my...
More about PXMD
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email